Anebulo Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Anebulo Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • Anebulo Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $59.7K.
Interest Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $59.7K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $31.8K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q1 2021 $3.7K Jan 1, 2021 Mar 31, 2021 10-Q 2021-06-21
Q2 2020 $1.29K Apr 23, 2020 Jun 30, 2020 10-K 2021-09-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.